MMCAP International’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

MMCAP International’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$2.52M	–	360
2022 Q4	$2.52M	Hold	250,000	–	–	0.26%	132
2022 Q3	$2.48M	Hold	250,000	–	–	0.2%	181
2022 Q2	$2.45M	Hold	250,000	–	–	0.2%	188
2022 Q1	$2.44M	Hold	250,000	–	–	0.14%	231
2021 Q4	$2.42M	Hold	250,000	–	–	0.15%	220
2021 Q3	$2.42M	Hold	250,000	–	–	0.17%	176
2021 Q2	$2.44K	Buy	+250,000	New	+$2.46M	0.12%	139

MMCAP International's EBAC Position: Q1 2023 in Review

MMCAP International sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 250,000 shares — an estimated $2.52M sold.

MMCAP International first reported a position in EBAC in Q2 2021 and held it in 7 quarters. The position peaked at $2.52M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

MMCAP International reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
MMCAP International sold 250,000 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $2.52M.
MMCAP International first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
MMCAP International's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $2.52M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.